2019 antibacterial agents in clinical development: an analysis of the antibacterial clinical development...
This report is the World Health Organization’s (WHO) third annual review of the clinical antibacterial pipeline to analyse how the pipeline responds...
2020 antibacterial agents in clinical and preclinical development: an overview and analysis
The World Health Organization’s (WHO) 2020 annual review of the clinical and preclinical antibacterial pipelines evaluates the potential of antibacterial...
2021 Antibacterial agents in clinical and preclinical development: an overview and analysis
The World Health Organization’s (WHO) “2021 Antibacterial agents in clinical and preclinical development: an overview and analysis” report...
2021 AWaRe classification
The AWaRe Classification of antibiotics was developed in 2017 by the WHO Expert Committee on Selection and Use of Essential Medicines as a tool to support...
Integrated drug resistance action framework for HIV, hepatitis B and C and sexually transmitted infections,...
The Integrated Drug Resistance Action Framework for HIV, Hepatitis B and C, and Sexually Transmitted Infections (2026–2030) outlines a unified...